D Jerene1, W Abebe2, K Taye3, P G Suarez4, Y Feleke5, I Hallström6, A J Ruff7. 1. Management Sciences for Health, Addis Ababa, Ethiopia. 2. Department of Paediatrics and Child Health, Addis Ababa University, Addis Ababa, Ethiopia. 3. Department of Paediatrics and Child Health, Hawassa University, Hawassa, Ethiopia. 4. Management Sciences for Health, Health Programs Group, Arlington, Virginia, USA. 5. Department of Internal Medicine, Addis Ababa University, Addis Ababa, Ethiopia. 6. Faculty of Medicine, Department of Health Sciences, Lund University, Lund, Sweden. 7. Bloomberg School of Public Health, Department of International Health, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract
SETTING: Eight health facilities in Ethiopia. OBJECTIVE: To determine tuberculosis (TB) incidence rates and associated factors among adolescents living with the human immunodeficiency virus (ALHIV). DESIGN: This was a retrospective cohort study. Adolescents enrolled in HIV care between January 2005 and 31 December 2013 constituted the study population. The main outcome variable was TB diagnosis during follow-up. Baseline World Health Organization (WHO) clinical stage, CD4 count, previous history of TB and use of isoniazid preventive therapy (IPT) were the main independent variables. We estimated TB incidence rates as incident cases per 100 person-years of observation (PYO). Cox regression analysis was used to control for confounders. RESULTS: Of the 1221 adolescents screened, 1072 were studied; 60.1% were girls. TB incidence rate was 16.32 per 100 PYO during pre-antiretroviral therapy (pre-ART) follow-up but declined to 2.25 per 100 PYO after initiation of ART. Advanced WHO clinical stage (adjusted hazard ratio [aHR] 2.71, 95%CI 1.69-4.33) and CD4 count <350 cells/μl (aHR 2.28, 95%CI 1.10-4.81) predicted TB incidence in the pre-ART cohort. IPT use was associated with a significant reduction in TB incidence in the ART cohort, but not in the pre-ART group. CONCLUSION: Although TB was a significant problem in ALHIV, timely administration of ART and IPT had a significant protective effect.
SETTING: Eight health facilities in Ethiopia. OBJECTIVE: To determine tuberculosis (TB) incidence rates and associated factors among adolescents living with the human immunodeficiency virus (ALHIV). DESIGN: This was a retrospective cohort study. Adolescents enrolled in HIV care between January 2005 and 31 December 2013 constituted the study population. The main outcome variable was TB diagnosis during follow-up. Baseline World Health Organization (WHO) clinical stage, CD4 count, previous history of TB and use of isoniazid preventive therapy (IPT) were the main independent variables. We estimated TB incidence rates as incident cases per 100 person-years of observation (PYO). Cox regression analysis was used to control for confounders. RESULTS: Of the 1221 adolescents screened, 1072 were studied; 60.1% were girls. TB incidence rate was 16.32 per 100 PYO during pre-antiretroviral therapy (pre-ART) follow-up but declined to 2.25 per 100 PYO after initiation of ART. Advanced WHO clinical stage (adjusted hazard ratio [aHR] 2.71, 95%CI 1.69-4.33) and CD4 count <350 cells/μl (aHR 2.28, 95%CI 1.10-4.81) predicted TB incidence in the pre-ART cohort. IPT use was associated with a significant reduction in TB incidence in the ART cohort, but not in the pre-ART group. CONCLUSION: Although TB was a significant problem in ALHIV, timely administration of ART and IPT had a significant protective effect.
Authors: B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; L J Nelson; D A Enarson; P R Donald; N Beyers Journal: Int J Tuberc Lung Dis Date: 2004-03 Impact factor: 2.373
Authors: Ben J Marais; Robert P Gie; H Simon Schaaf; Nulda Beyers; Peter R Donald; Jeff R Starke Journal: Am J Respir Crit Care Med Date: 2006-02-16 Impact factor: 21.405
Authors: Amelia C Crampin; J Nimrod Mwaungulu; Frank D Mwaungulu; D Totah Mwafulirwa; Kondwani Munthali; Sian Floyd; Paul Em Fine; Judith R Glynn Journal: AIDS Date: 2010-01-28 Impact factor: 4.177